Document Type : Review Articles
Authors
1
Department of Pharmaceutics, Faculty of Pharmacy, Minia University, 61519 Minia, Egypt. Department of Pharmaceutics, Faculty of Pharmacy, Merit University Egypt (MUE), Sohag, Egypt.
2
Pharmaceutics Department, Faculty of Pharmacy, Minia University, 61519 Minia, Egypt.
3
Department of Pharmaceutics, Faculty of Pharmacy, Minia University, 61519 Minia, Egypt.
4
Assuit International Center of Nanomedicine, Al-Rajhy Liver Hospital, Assuit University, Assuit, 71515, Egypt.
5
Pharmaceutics Department, Faculty Of Pharmacy, Minia University, 61519 Minia, Egypt.
Abstract
Drug delivery systems based on nanotechnology have been significant in surpassing the challenges associated with traditional dose forms. A promising drug delivery vehicle is spanlastics, an elastic nanovesicle that can transport a variety of drug compounds. Spanlastics have shown an increasing amount of interest in various forms of administrative pathways. They may squeeze themselves through skin pores because they are elastic and malleable, making them ideal for transdermal delivery. Non-ionic surfactants or mixtures of surfactants make up spanlastics. Numerous studies have demonstrated how spanlastics greatly improve drug toxicity, drug bioavailability, and therapeutic efficacy. Our future goal is to evaluate the spanlastic-encapsulated carbapenem's antibacterial and anti-biofilm characteristics. Following the isolation of Staphylococcus epidermidis isolates and the assessment of their microbiological sensitivity, the plate microtiter test was employed to investigate their capacity to form biofilms.
Keywords
Main Subjects
)
View on SCiNiTO